Your browser doesn't support javascript.
loading
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial.
Wang, Wenjuan; Liang, Qi; Zhu, Jiahong; Zhang, Junxia; Chen, Junsheng; Xie, Sulan; Hu, Yuemei; Li, Guifan.
Afiliação
  • Wang W; Vaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu, China.
  • Liang Q; Vaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu, China.
  • Zhu J; Department of Acute Infectious Disease Control and Prevention, Lianshui County Center for Disease Control and Prevention, Jiangsu, China.
  • Zhang J; Department of Acute Infectious Disease Control and Prevention, Huaiyin District Center for Disease Control and Prevention, Jiangsu, China.
  • Chen J; Vice Director, Hongze District Center for Disease Control and Prevention, Jiangsu, China.
  • Xie S; Administration Office, Hongze District Center for Disease Control and Prevention, Jiangsu, China.
  • Hu Y; Vaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu, China.
  • Li G; Registration Department, Beijing Minhai Biotechnology Co., LTD., Beijing, China.
Hum Vaccin Immunother ; 18(1): 2019498, 2022 12 31.
Article em En | MEDLINE | ID: mdl-35192784
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas Tipo de estudo: Clinical_trials Limite: Humans / Infant País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas Tipo de estudo: Clinical_trials Limite: Humans / Infant País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article